[Abstract Only] Observational Study: Renin-Angiotensin System Inhibition May Improve Prognosis Following Transcatheter Aortic Valve Replacement
6 Aug, 2019 | 07:53h | UTCRenin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentaries: RAS Inhibition After TAVR Gains More Support, but RCT Still Needed – TCTMD (free) AND Renin-angiotensin system inhibition following transcatheter aortic valve replacement linked with lower cardiac mortality – 2 Minute Medicine (free)
Related Commentary on Twitter
Renin-angiotensin system inhibitors may improve outcomes after #TAVR. View data collected from over 2,500 patients with severe #vhdAS in #JACC. https://t.co/htFLXsS2l2 pic.twitter.com/aOIzwdETX2
— JACC Journals (@JACCJournals) August 5, 2019